What is the appropriate management of a myasthenia gravis crisis?

Myasthenia Gravis Crisis Management

Immediately admit the patient to an ICU-capable unit, secure the airway if respiratory failure is present, initiate IVIG 2 g/kg over 5 days (0.4 g/kg/day) or plasmapheresis for 5 days, start high-dose corticosteroids, and permanently discontinue any immune checkpoint inhibitors if applicable.

Initial Assessment and Stabilization

Airway and Respiratory Management

The cornerstone of myasthenic crisis management is immediate recognition of respiratory failure and airway protection 1. Crisis is defined by respiratory insufficiency requiring invasive or non-invasive ventilation, often from respiratory muscle weakness or bulbar weakness with upper airway collapse 2.

Key respiratory monitoring parameters:

• Negative inspiratory force (NIF) and vital capacity (VC) measurements 1
• Frequent pulmonary function assessments (serial measurements throughout crisis) 1
• Intubate emergently if NIF deteriorates (e.g., -12 to -10) or patient cannot clear secretions 3

Immediate Diagnostic Workup

While stabilizing the patient, obtain 1:

• Acetylcholine receptor (AChR) and antistriated muscle antibodies - if AChR negative, check MuSK and LRP4 antibodies (absence doesn't rule out crisis)
• Troponin and ECG - myocarditis frequently coexists and dramatically worsens prognosis
• CPK, aldolase, ESR, CRP - evaluate for concurrent myositis
• Consider cardiac MRI or echocardiogram if troponin elevated or respiratory insufficiency present
• Electrodiagnostic studies under neurology consultation: repetitive nerve stimulation, jitter studies, EMG

Acute Immunotherapy (Grade 3-4 Crisis)

First-Line Treatment

Plasmapheresis is preferred over IVIG for myasthenic crisis 2. The 2021 ASCO guidelines specify 1:

Plasmapheresis regimen:

• 5 sessions over 5 days
• Provides more rapid improvement than IVIG
• Superior outcomes demonstrated in crisis management

Alternative - IVIG:

• 2 g/kg IV total dose over 5 days (0.4 g/kg/day) 1
• Use if plasmapheresis unavailable or contraindicated

Corticosteroid Therapy

Initiate high-dose corticosteroids immediately 1:

• Prednisone 0.5-1 mg/kg orally daily for crisis
• Begin steroid taper 3-4 weeks after initiation
• Wean based on symptom improvement and clinical response
• Continue until patient stabilizes

Refractory Cases

If no response to IVIG or plasmapheresis, add rituximab 1. This represents the escalation pathway for treatment-resistant crisis.

Symptomatic Treatment

Acetylcholinesterase Inhibitors

Pyridostigmine dosing 1:

• Start 30 mg PO three times daily
• Gradually increase to maximum 120 mg PO four times daily
• Titrate based on symptoms and tolerance
• Wean as immunotherapy takes effect

Critical Medication Avoidance

Immediately discontinue and avoid medications that worsen myasthenia 1:

• Beta-blockers
• IV magnesium
• Fluoroquinolones
• Aminoglycosides
• Macrolide antibiotics

This is non-negotiable - these agents can precipitate or worsen crisis.

Ongoing Monitoring

Daily requirements during crisis 1:

• Daily neurologic examination by neurology consultant
• Frequent pulmonary function testing (NIF/VC multiple times daily)
• Continuous ICU-level monitoring capability
• Assessment for triggers (infections most common, though 30-40% have no identifiable trigger) 2

Prognosis and Weaning

Most patients wean from mechanical ventilation within 1 month 2. Mortality in U.S. cohorts is less than 5%, driven primarily by age and medical comorbidities rather than the crisis itself 2. The crisis does not appear to affect long-term prognosis - many patients achieve good disease control afterward 2.

Special Considerations

Immune Checkpoint Inhibitor-Associated Crisis

If crisis occurs in context of cancer immunotherapy 1:

• Permanently discontinue the immune checkpoint inhibitor (this is absolute for Grade 3-4)
• Same acute management as above
• May be monophasic, potentially not requiring long-term immunosuppression

Concurrent Myocarditis

Cardiac involvement dramatically changes management 1:

• Obtain troponin, ECG, and echocardiogram in all crisis patients
• If myocarditis present, this becomes a medical emergency requiring aggressive immunotherapy
• Consider cardiac MRI for definitive diagnosis

Common Pitfalls

1. Delaying intubation - Don't wait for complete respiratory failure; deteriorating NIF values mandate early airway protection
2. Missing concurrent myocarditis - Always check troponin; myocarditis significantly increases mortality
3. Continuing contraindicated medications - Review entire medication list immediately
4. Inadequate immunotherapy - Crisis requires aggressive treatment; don't undertreate with steroids alone